HOME >> MEDICINE >> NEWS
Major risk factors identified for sudden infant death syndrome

Results of European research in this week's issue of THE LANCET highlight how basic child-care strategies-such as preventing babies from sleeping face-down, using appropriate bedding, and discouraging bed-sharing with mothers who smoke-could reduce the risk of 'cot death' (sudden unexplained infant death syndrome [SIDS]).

Four large studies were set up to re-examine the epidemiology of SIDS after striking changes in rates of this phenomenon around 1990. The European Concerted Action on SIDS (ECAS) investigation brings together data from these and new studies to give an overview of risk factors for the syndrome in Europe.

745 SIDS cases and around 2400 controls were obtained from 20 European centres. Major factors increasing risk of SIDS were: prone (face-down) sleeping position of infant; turning the infant from side to prone position; infant head-covering with bedding; household smoking; bed-sharing with a mother who smoked; bed-sharing with non-smoking mother for infants up to eight weeks of age; and mothers' alcohol consumption over previous 24 hours (if bed-sharing with an infant).

Lead investigator Robert Carpenter from the London School of Hygiene and Tropical Medicine, UK, comments: "Avoidable risk factors such as those associated with inappropriate infants' sleeping position, type of bedding used, and sleeping arrangements strongly suggest a basis for further substantial reductions in SIDS incidence rates."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
15-Jan-2004


Page: 1

Related medicine news :

1. Major review of subway systems suggests potential for significant health and safety hazards
2. Major step forwards for vaccine against cervical cancer
3. Majority of cigarettes in the US smoked by nicotine-dependent or psychiatrically ill persons
4. Major overhaul needed in end-of life care for patients with dementia
5. Major overhaul needed in end-of life care for patients with dementia
6. Major radiology journal offers unrestricted access to recently archived articles
7. Major study: Bioartificial liver reduces mortality by 44 percent in acute liver-failure patients
8. Majority of authors retract 1998 Lancet paper-Lancet editor points to implications
9. Major agreement reached at heart health conference
10. Major cause of painful gastroenteritis under study at MCG
11. Major advance in chemotherapy in breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Major risk factors identified for sudden infant death syndrome

(Date:5/18/2013)... COOLA, British Columbia (PRWEB) May 19, 2013 ... to Cooking” (published by iUniverse) , author Janet Hall Svisdahl’s ... delectable world recipes sure to make even the pickiest ... living peacefully, pleasurably and prayerfully,” she explains. , Found ... Spirit” are a wide range of delicious recipes, from fast ...
(Date:5/18/2013)... 2013) The American Gastroenterological Association (AGA) Research ... scholars. This year,s honorees are outstanding young gastroenterologists ... related areas, and with this award, their research ... researchers are the future of our field. AGA ... paving the way for promising research developments and ...
(Date:5/18/2013)... Thompson HealthDay Reporter , , FRIDAY, May 17 ... the latest edition of what is considered the "bible" ... many changes continues. "This is unprecedented, the amount ... Lieberman, president-elect of the American Psychiatric Association (APA). "It,s ... it is. You have to evaluate it and then ...
(Date:5/18/2013)... Orlando, FL (May 18, 2013) The use ... for a colonoscopy, according to new research presented ... process, which begins days in advance of the ... preparation medication to be taken at strict intervals. ... for doctors to see cancer and precancerous polyps ...
(Date:5/18/2013)... 18, 2013 Assisted living and ... to safety and comfort of their residents. Systems ... clients with an effective and cost-efficient solution – ... an integrated, turnkey communications solution that helps nurses ... residents independence and privacy. , The VisionLink ...
Breaking Medicine News(10 mins):Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:AGA Research Foundation Research Scholar Awards advance the work of promising gastroenterologists 2Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 2Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 3Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 4Health News:New smartphone application improves colonoscopy preparation 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3
(Date:5/17/2013)... 2013 Sinovac Biotech Ltd. (Nasdaq: SVA ... , today announced that it will release its unaudited ... before market on Tuesday, May 28, 2013.  The Company will ... 8:00 a.m. EDT (May 28, 2013 at 8:00 p.m. China ... an update on recent corporate developments. To access ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... and Research (A*STAR) and Switzerland,s Cytos ... been dosed in a Phase 1 clinical trial with their ... virus-like particle (VLP) technology. In this first Phase 1 clinical ... and its potential to protect against H1N1 influenza infection will ...
(Date:5/16/2013)... N.J. , May 16, 2013  PTC Therapeutics, ... statement on Form S-1 with the U.S. Securities and ... offering of its common stock. The number of shares ... offering have not been determined. (Logo:  ... Suisse are acting as joint book-running managers for the ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
Cached News: